MarketCap
Facebook
X
Telegram
Intuitive Surgical Retained Earnings | ISRG
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Intuitive Surgical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.01 B | 6.8 B | 4.74 B | 3.5 B | 4.76 B | 3.26 B | 2.49 B | 1.52 B | 61.4 M | 1.57 B | 899 M | 488 M | 979 M | 1.33 B | 902 M | 719 M | 512 M | 398 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.01 B | 61.4 M | 2.33 B |
Quarterly Retained Earnings Intuitive Surgical
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.84 B | 6.4 B | 7.01 B | 6.42 B | 7.61 B | 7.14 B | 6.8 B | 6.13 B | 5.58 B | 5.07 B | 4.74 B | 4.21 B | - | 3.4 B | 3.5 B | 4.02 B | - | 4.86 B | 4.76 B | 4.39 B | 4.02 B | 3.51 B | 3.26 B | 3.26 B | 3.26 B | 3.26 B | 2.49 B | 2.49 B | 2.49 B | 2.49 B | 1.52 B | 1.52 B | 1.52 B | 1.52 B | 115 M | 115 M | 115 M | 115 M | 1.57 B | 1.57 B | 1.57 B | 1.57 B | 899 M | 899 M | 899 M | 899 M | 488 M | 488 M | 488 M | 488 M | 979 M | 979 M | 979 M | 979 M | 1.33 B | 1.33 B | 1.33 B | 1.33 B | 902 M | 902 M | 902 M | 902 M | 720 M | 686 M | 597 M | 434 M | 370 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.61 B | 115 M | 2.52 B |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
-413 M | $ 35.04 | 6.18 % | $ 1.67 B |  USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
BioLife Solutions
BLFS
|
-340 M | $ 29.98 | -2.57 % | $ 1.43 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
ResMed
RMD
|
6.08 B | $ 195.27 | 1.76 % | $ 28.6 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
STAAR Surgical Company
STAA
|
-148 M | $ 23.38 | -3.35 % | $ 1.16 B | USA |
 |
STERIS plc
STE
|
3.02 B | $ 214.07 | 1.64 % | $ 21 B | USA |
 |
Teleflex Incorporated
TFX
|
3.15 B | $ 132.1 | 0.69 % | $ 5.89 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-262 M | - | - | $ 28.6 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
Nephros
NEPH
|
-143 M | $ 3.64 | -3.45 % | $ 38.6 M | USA |
 |
West Pharmaceutical Services
WST
|
4.37 B | $ 328.2 | -7.67 % | $ 23.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-1.56 B | $ 12.93 | 1.65 % | $ 2.58 B | USA |
 |
Isoray
ISR
|
-335 M | - | 0.03 % | $ 108 M | USA |
 |
electroCore
ECOR
|
-191 M | $ 6.19 | -2.75 % | $ 52.5 K | USA |
 |
Haemonetics Corporation
HAE
|
279 M | $ 78.78 | 1.78 % | $ 3.72 B | USA |
 |
Predictive Oncology
POAI
|
-414 M | - | - | $ 31.1 M | USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 70.31 | 0.11 % | $ 14 B | USA |
 |
AngioDynamics
ANGO
|
-466 M | $ 13.59 | 1.12 % | $ 564 M | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
Pulse Biosciences
PLSE
|
-463 M | $ 30.23 | -2.48 % | $ 2.04 B | USA |
 |
iRhythm Technologies
IRTC
|
-803 M | $ 109.2 | 1.42 % | $ 3.49 B | USA |
 |
Repligen Corporation
RGEN
|
456 M | $ 131.96 | -4.1 % | $ 7.42 M | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 54.93 | 0.48 % | $ 181 M | USA |
 |
Merit Medical Systems
MMSI
|
824 M | $ 74.32 | 1.66 % | $ 4.4 B | USA |
 |
InfuSystem Holdings
INFU
|
-60.7 M | $ 9.12 | 2.59 % | $ 188 M | USA |
 |
Glaukos Corporation
GKOS
|
-933 M | $ 153.58 | 0.95 % | $ 8.78 B | USA |
 |
Baxter International
BAX
|
13.7 B | $ 22.4 | 3.37 % | $ 11.5 B | USA |
 |
Harvard Bioscience
HBIO
|
-215 M | $ 6.0 | -3.56 % | $ 266 M | USA |
 |
ICU Medical
ICUI
|
691 M | $ 157.44 | 2.59 % | $ 3.88 B | USA |
 |
Alcon
ALC
|
19.4 B | $ 67.91 | 1.04 % | $ 40.4 B |  Schweiz |
 |
Stereotaxis
STXS
|
-583 M | $ 1.29 | -8.51 % | $ 117 M | USA |
 |
Milestone Scientific
MLSS
|
-134 M | $ 0.39 | -2.94 % | $ 32 M | USA |
 |
Envista Holdings Corporation
NVST
|
-440 M | $ 26.33 | 0.61 % | $ 4.42 B | USA |
 |
Masimo Corporation
MASI
|
1.49 B | - | - | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
-104 M | $ 1.71 | -2.84 % | $ 78.3 M |  Israel |
 |
Repro Med Systems
KRMD
|
-32 M | $ 3.83 | 2.68 % | $ 177 M | USA |
 |
OraSure Technologies
OSUR
|
-172 M | $ 3.97 | -1.49 % | $ 292 M | USA |
 |
LeMaitre Vascular
LMAT
|
185 M | $ 95.59 | -1.95 % | $ 2.16 B | USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 156.36 | 2.22 % | $ 45 B | USA |
 |
Retractable Technologies
RVP
|
13.9 M | $ 0.68 | - | $ 20.4 M | USA |
 |
Utah Medical Products
UTMD
|
129 M | $ 67.14 | 4.61 % | $ 218 M | USA |